Related Experiment Video
Updated: Mar 12, 2026

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and
Cheng-Cao Sun1, Shu-Jun Li1,2, Guang Li3
1Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, P. R. China.
Abstract:
Long noncoding RNAs (lncRNAs) play crucial roles in carcinogenesis. However, the function and mechanism of lncRNAs in human non-small-cell lung cancer (NSCLC) are still remaining largely unknown. Long intergenic noncoding RNA 00511 (LINC00511) has been found to be upregulated and acts as an oncogene in breast cancer, but little is known about its expression pattern, biological function and underlying mechanism in NSCLC. Herein, we identified LINC00511 as an oncogenic lncRNA by driving tumorigenesis in NSCLC. We found LINC00511 was upregulated and associated with oncogenesis, tumor size, metastasis, and poor prognosis in NSCLC. Moreover, LINC00511 affected cell proliferation, invasiveness, metastasis, and apoptosis in multiple NSCLC cell lines. Mechanistically, LINC00511 bound histone methyltransferase enhancer of zeste homolog 2 ((EZH2, the catalytic subunit of the polycomb repressive complex 2 (PRC2), a highly conserved protein complex that regulates gene expression by methylating lysine 27 on histone H3), and acted as a modular scaffold of EZH2/PRC2 complexes, coordinated their localization, and specified the histone modification pattern on the target genes, including p57, and consequently altered NSCLC cell biology. Thus, LINC00511 is mechanistically, functionally, and clinically oncogenic in NSCLC. Targeting LINC00511 and its pathway may be meaningful for treating patients with NSCLC.
Insights
Long noncoding RNA 00511 (LINC00511) drives non-small-cell lung cancer (NSCLC) by promoting tumor growth and metastasis. Targeting LINC00511 may offer a new therapeutic strategy for NSCLC patients.
Area of Science:
- * Molecular Oncology
- * Cancer Genomics
Background:
- * Long noncoding RNAs (lncRNAs) are implicated in cancer development.
- * The role of LINC00511 in non-small-cell lung cancer (NSCLC) remains largely unexplored.
- * Previous studies suggest LINC00511 acts as an oncogene in breast cancer.
Purpose of the Study:
- * To investigate the expression, function, and mechanism of LINC00511 in NSCLC.
- * To determine if LINC00511 is an oncogenic driver in NSCLC.
- * To explore the potential of LINC00511 as a therapeutic target in NSCLC.
Main Methods:
- * Analysis of LINC00511 expression in NSCLC tissues and cell lines.
- * Functional assays assessing cell proliferation, invasion, metastasis, and apoptosis.
- * Mechanistic studies involving chromatin immunoprecipitation and Western blotting to elucidate LINC00511's interaction with EZH2/PRC2 complex and target genes like p57.
Main Results:
- * LINC00511 is significantly upregulated in NSCLC and correlates with tumor progression and poor prognosis.
- * LINC00511 promotes NSCLC cell proliferation, invasion, and metastasis while inhibiting apoptosis.
- * LINC00511 functions as a scaffold for the EZH2/PRC2 complex, altering histone modifications on target genes such as p57, thereby impacting NSCLC cell biology.
Conclusions:
- * LINC00511 is an oncogenic lncRNA in NSCLC, mechanistically, functionally, and clinically.
- * LINC00511 promotes NSCLC tumorigenesis by interacting with the EZH2/PRC2 complex.
- * Targeting LINC00511 and its associated pathway presents a promising therapeutic strategy for NSCLC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Inheritance of Chromatin Structures